2023 Q3 Form 10-Q Financial Statement

#000010203723000048 Filed on August 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $635.8M $517.7M $429.8M
YoY Change -2.18% 20.45% 22.8%
Cost Of Revenue $506.8M $431.2M $350.1M
YoY Change -6.28% 23.17% 21.75%
Gross Profit $129.0M $86.51M $79.72M
YoY Change 18.08% 8.52% 27.6%
Gross Profit Margin 20.3% 16.71% 18.55%
Selling, General & Admin $73.81M $75.48M $66.45M
YoY Change 1.98% 13.58% 33.32%
% of Gross Profit 57.2% 87.24% 83.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $14.26M $14.75M $14.13M
YoY Change 0.64% 4.42% 17.18%
% of Gross Profit 11.05% 17.05% 17.72%
Operating Expenses $73.81M $75.48M $66.45M
YoY Change 1.98% 13.58% 33.32%
Operating Profit $55.31M $11.03M $13.27M
YoY Change 46.0% -16.82% 25.09%
Interest Expense $17.05M -$18.34M $6.724M
YoY Change 38.98% -372.81% 8.31%
% of Operating Profit 30.83% -166.23% 50.69%
Other Income/Expense, Net $728.0K $725.0K -$62.00K
YoY Change -1045.45% -1269.35% -229.17%
Pretax Income $39.23M -$6.584M $6.164M
YoY Change 50.6% -206.81% 20.23%
Income Tax $8.439M -$1.423M $3.363M
% Of Pretax Income 21.51% 54.56%
Net Earnings $28.13M -$2.064M $6.830M
YoY Change 28.7% -130.22% 7.44%
Net Earnings / Revenue 4.42% -0.4% 1.59%
Basic Earnings Per Share $1.13 -$0.08 $0.28
Diluted Earnings Per Share $1.12 -$0.08 $0.27
COMMON SHARES
Basic Shares Outstanding 24.64M shares 24.56M shares 24.77M shares
Diluted Shares Outstanding 25.02M shares 24.84M shares 24.94M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $99.68M $80.52M $86.57M
YoY Change 69.37% -6.99% 2.22%
Cash & Equivalents $99.68M $80.52M $86.57M
Short-Term Investments
Other Short-Term Assets $95.63M $114.8M $90.38M
YoY Change 8.79% 27.01% 6.31%
Inventory $1.404B $1.411B $1.379B
Prepaid Expenses
Receivables $368.9M $375.6M $319.1M
Other Receivables $55.41M $73.29M $48.51M
Total Short-Term Assets $2.048B $2.055B $1.935B
YoY Change 2.83% 6.18% 20.61%
LONG-TERM ASSETS
Property, Plant & Equipment $356.6M $393.8M $345.1M
YoY Change 4.65% 14.12% -1.86%
Goodwill $213.9M $213.9M $213.9M
YoY Change 0.02% 0.0% 23.61%
Intangibles $74.48M $77.29M $89.35M
YoY Change -13.53% -13.5% 27.82%
Long-Term Investments $70.62M $73.47M $75.19M
YoY Change -0.37% -2.29% -11.61%
Other Assets $35.34M $74.38M $52.36M
YoY Change -4.09% 42.07% 2.83%
Total Long-Term Assets $814.1M $832.9M $844.2M
YoY Change -1.04% -1.35% 6.64%
TOTAL ASSETS
Total Short-Term Assets $2.048B $2.055B $1.935B
Total Long-Term Assets $814.1M $832.9M $844.2M
Total Assets $2.862B $2.888B $2.779B
YoY Change 1.7% 3.9% 16.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $70.90M $89.86M $235.6M
YoY Change -57.58% -61.86% 49.11%
Accrued Expenses $157.9M $159.1M $26.50M
YoY Change 398.32% 500.46% -0.27%
Deferred Revenue $166.5M $103.4M $19.44M
YoY Change 1216.87% 432.13% 108.85%
Short-Term Debt $301.4M $359.8M $454.7M
YoY Change -48.25% -20.86% 196.51%
Long-Term Debt Due $0.00 $0.00 $0.00
YoY Change
Total Short-Term Liabilities $701.1M $717.9M $742.0M
YoY Change -12.19% -3.25% 110.1%
LONG-TERM LIABILITIES
Long-Term Debt $617.1M $616.9M $518.8M
YoY Change 18.92% 18.92% 0.1%
Other Long-Term Liabilities $15.77M $95.23M $30.02M
YoY Change 3.05% 217.17% -49.81%
Total Long-Term Liabilities $632.9M $712.2M $548.8M
YoY Change 18.46% 29.76% -5.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $701.1M $717.9M $742.0M
Total Long-Term Liabilities $632.9M $712.2M $548.8M
Total Liabilities $1.444B $1.507B $1.419B
YoY Change -1.03% 6.17% 34.59%
SHAREHOLDERS EQUITY
Retained Earnings $1.120B $1.115B $1.081B
YoY Change 3.58% 3.1% 0.63%
Common Stock $339.2M $338.4M $332.5M
YoY Change 1.71% 1.78% 1.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.384B $1.381B $1.326B
YoY Change
Total Liabilities & Shareholders Equity $2.862B $2.888B $2.779B
YoY Change 1.7% 3.9% 16.0%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $28.13M -$2.064M $6.830M
YoY Change 28.7% -130.22% 7.44%
Depreciation, Depletion And Amortization $14.26M $14.75M $14.13M
YoY Change 0.64% 4.42% 17.18%
Cash From Operating Activities $114.4M -$103.9M -$225.8M
YoY Change -194.98% -53.98% 77.88%
INVESTING ACTIVITIES
Capital Expenditures $14.67M $17.96M $15.07M
YoY Change -227.37% 19.18% 4.45%
Acquisitions
YoY Change
Other Investing Activities $4.144M $326.0K $1.460M
YoY Change 206.51% -77.67% -8.12%
Cash From Investing Activities -$10.53M -$17.63M -$13.61M
YoY Change 3.54% 29.57% 6.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -84.36M 137.3M $245.5M
YoY Change -181.34% -44.05% 804.1%
NET CHANGE
Cash From Operating Activities 114.4M -103.9M -$225.8M
Cash From Investing Activities -10.53M -17.63M -$13.61M
Cash From Financing Activities -84.36M 137.3M $245.5M
Net Change In Cash 19.54M 15.82M $4.918M
YoY Change -172.57% 221.76% -104.37%
FREE CASH FLOW
Cash From Operating Activities $114.4M -$103.9M -$225.8M
Capital Expenditures $14.67M $17.96M $15.07M
Free Cash Flow $99.76M -$121.9M -$240.8M
YoY Change -191.55% -49.41% 70.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5000 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1400000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-23457000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-68032000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
263171000 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
281844000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4240000 usd
CY2022Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
16739000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1110000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-50200000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
7833000 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
16529000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2336000 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-581000 usd
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
100473000 usd
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
6191000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-103891000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-225771000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17960000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15070000 usd
CY2023Q2 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 usd
CY2022Q2 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
1168000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80518000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86566000 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
6000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80518000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92566000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
516370000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
429122000 usd
CY2023Q2 us-gaap Other Operating Income
OtherOperatingIncome
1352000 usd
CY2022Q2 us-gaap Other Operating Income
OtherOperatingIncome
700000 usd
CY2023Q2 us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
517722000 usd
CY2022Q2 us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
429822000 usd
CY2023Q2 uvv Other Contingent Liabilities
OtherContingentLiabilities
1000000 usd
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 usd
CY2023Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
100000000 usd
CY2023Q2 uvv Sales Agreement To Sell Common Stock Of Subsidiary Company Value
SalesAgreementToSellCommonStockOfSubsidiaryCompanyValue
8500000 usd
CY2023Q2 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
5700000 usd
CY2023Q2 uvv Sales Agreement To Sell Common Stock Of Subsidiary Company Value
SalesAgreementToSellCommonStockOfSubsidiaryCompanyValue
8500000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2064000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
6830000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24842171 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24769015 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2064000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
6830000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24842171 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24769015 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
166539 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24842171 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24935554 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.216
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.546
CY2023Q1 us-gaap Goodwill
Goodwill
213922000 usd
CY2022Q1 us-gaap Goodwill
Goodwill
213998000 usd
CY2023Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-29000 usd
CY2022Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-96000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
213893000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
213902000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
111637000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
34347000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
77290000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
111590000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22238000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
89352000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
111621000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
31520000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
80101000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2827000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3173000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
8452000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
11049000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9232000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
8077000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
40480000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
77290000 usd
CY2023Q2 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
8037000 usd
CY2022Q2 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
5503000 usd
CY2023Q1 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
7102000 usd
CY2023Q2 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
1674000 usd
CY2022Q2 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
393000 usd
CY2023Q1 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
3967000 usd
CY2023Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
787000 usd
CY2022Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
7531000 usd
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
1320000 usd
CY2023Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
2841000 usd
CY2022Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
12000 usd
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
435000 usd
CY2023Q2 us-gaap Alternative Investment
AlternativeInvestment
566000 usd
CY2023Q2 us-gaap Trading Securities
TradingSecurities
11884000 usd
CY2023Q2 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
5810000 usd
CY2023Q2 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
3014000 usd
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
21274000 usd
CY2023Q2 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
4515000 usd
CY2023Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
4515000 usd
CY2022Q2 us-gaap Alternative Investment
AlternativeInvestment
334000 usd
CY2022Q2 us-gaap Trading Securities
TradingSecurities
11666000 usd
CY2022Q2 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
4345000 usd
CY2022Q2 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
8689000 usd
CY2022Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
25034000 usd
CY2022Q2 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
405000 usd
CY2022Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
405000 usd
CY2023Q1 us-gaap Alternative Investment
AlternativeInvestment
400000 usd
CY2023Q1 us-gaap Trading Securities
TradingSecurities
11698000 usd
CY2023Q1 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
8422000 usd
CY2023Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
20520000 usd
CY2023Q1 us-gaap Interest Rate Derivative Liabilities At Fair Value
InterestRateDerivativeLiabilitiesAtFairValue
3077000 usd
CY2023Q1 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
1325000 usd
CY2023Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
4402000 usd
CY2023Q2 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
300000 usd
CY2023Q2 us-gaap Defined Benefit Plan Expected Future Employer Contributions Remainder Of Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
3600000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3900000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3700000 usd
CY2023Q2 uvv Expected Stock Based Compensation For Remaining Current Period
ExpectedStockBasedCompensationForRemainingCurrentPeriod
3700000 usd
CY2023Q2 us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
517722000 usd
CY2022Q2 us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
429822000 usd
CY2023Q2 uvv Equity In Pretax Earnings Of Unconsolidated Affiliates
EquityInPretaxEarningsOfUnconsolidatedAffiliates
-4166000 usd
CY2022Q2 uvv Equity In Pretax Earnings Of Unconsolidated Affiliates
EquityInPretaxEarningsOfUnconsolidatedAffiliates
-553000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
11035000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13266000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-72547000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-88066000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1436952000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1384769000 usd
CY2023Q2 uvv Adjustments To Common Stock Accrual Stock Based Compensation
AdjustmentsToCommonStockAccrualStockBasedCompensation
3859000 usd
CY2022Q2 uvv Adjustments To Common Stock Accrual Stock Based Compensation
AdjustmentsToCommonStockAccrualStockBasedCompensation
3682000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2963000 usd
CY2022Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2090000 usd
CY2023Q2 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
302000 usd
CY2022Q2 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
266000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-5161000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
2801000 usd
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
19710000 usd
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
19447000 usd
CY2023Q2 uvv Dividend Equivalent Shares Added To Restricted Stock Units Retained Earnings
DividendEquivalentSharesAddedToRestrictedStockUnitsRetainedEarnings
-302000 usd
CY2022Q2 uvv Dividend Equivalent Shares Added To Restricted Stock Units Retained Earnings
DividendEquivalentSharesAddedToRestrictedStockUnitsRetainedEarnings
-266000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4366000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4084000 usd
CY2023Q2 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
4164000 usd
CY2022Q2 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
5145000 usd
CY2023Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
0 usd
CY2022Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
427000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1413179000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1360059000 usd

Files In Submission

Name View Source Status
0000102037-23-000048-index-headers.html Edgar Link pending
0000102037-23-000048-index.html Edgar Link pending
0000102037-23-000048.txt Edgar Link pending
0000102037-23-000048-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uvv-20230630.htm Edgar Link pending
uvv-20230630.xsd Edgar Link pending
uvv-exhibit311x20230630.htm Edgar Link pending
uvv-exhibit312x20230630.htm Edgar Link pending
uvv-exhibit321x20230630.htm Edgar Link pending
uvv-exhibit322x20230630.htm Edgar Link pending
uvv-20230630_lab.xml Edgar Link unprocessable
uvv-20230630_pre.xml Edgar Link unprocessable
uvv-20230630_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
uvv-20230630_cal.xml Edgar Link unprocessable
uvv-20230630_def.xml Edgar Link unprocessable